All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 45.55
(-1.83%)
TWD 45.55
(-1.83%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 543.09 Million TWD | -42.38% |
| 2022 | 942.46 Million TWD | 202.74% |
| 2021 | 311.31 Million TWD | 537.4% |
| 2020 | 48.84 Million TWD | 41.7% |
| 2019 | 34.46 Million TWD | -82.19% |
| 2018 | 193.52 Million TWD | 49.19% |
| 2017 | 129.72 Million TWD | -65.74% |
| 2016 | 378.69 Million TWD | -47.81% |
| 2015 | 725.65 Million TWD | 20.88% |
| 2014 | 600.31 Million TWD | 26.45% |
| 2013 | 474.74 Million TWD | 53.46% |
| 2012 | 309.36 Million TWD | 34.01% |
| 2011 | 230.85 Million TWD | 88.95% |
| 2010 | 122.17 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 559.66 Million TWD | 3.05% |
| 2024 Q2 | 563.82 Million TWD | 0.74% |
| 2023 Q4 | 543.09 Million TWD | -0.85% |
| 2023 Q3 | 547.72 Million TWD | -0.35% |
| 2023 Q2 | 549.65 Million TWD | 0.06% |
| 2023 Q1 | 549.3 Million TWD | -41.72% |
| 2023 FY | 543.09 Million TWD | -42.38% |
| 2022 FY | 942.46 Million TWD | 202.74% |
| 2022 Q4 | 942.46 Million TWD | -30.41% |
| 2022 Q3 | 1.35 Billion TWD | 173.14% |
| 2022 Q2 | 495.83 Million TWD | 40.87% |
| 2022 Q1 | 351.96 Million TWD | 13.06% |
| 2021 FY | 311.31 Million TWD | 537.4% |
| 2021 Q1 | 158.88 Million TWD | 225.31% |
| 2021 Q2 | 4.28 Million TWD | -97.3% |
| 2021 Q3 | 264.87 Million TWD | 6085.78% |
| 2021 Q4 | 311.31 Million TWD | 17.53% |
| 2020 FY | 48.84 Million TWD | 41.7% |
| 2020 Q2 | 183.13 Million TWD | 66.9% |
| 2020 Q3 | 29.47 Million TWD | -83.9% |
| 2020 Q4 | 48.84 Million TWD | 65.7% |
| 2020 Q1 | 109.72 Million TWD | 218.35% |
| 2019 Q1 | 284.37 Million TWD | 46.94% |
| 2019 Q3 | 32.6 Million TWD | -84.9% |
| 2019 FY | 34.46 Million TWD | -82.19% |
| 2019 Q2 | 215.86 Million TWD | -24.09% |
| 2019 Q4 | 34.46 Million TWD | 5.73% |
| 2018 Q2 | 572.46 Million TWD | 75.32% |
| 2018 FY | 193.52 Million TWD | 49.19% |
| 2018 Q4 | 193.52 Million TWD | -39.53% |
| 2018 Q3 | 320.01 Million TWD | -44.1% |
| 2018 Q1 | 326.52 Million TWD | 151.71% |
| 2017 FY | 129.72 Million TWD | -65.74% |
| 2017 Q1 | 187.16 Million TWD | -50.58% |
| 2017 Q2 | 432.07 Million TWD | 130.86% |
| 2017 Q3 | 243.19 Million TWD | -43.71% |
| 2017 Q4 | 129.72 Million TWD | -46.66% |
| 2016 FY | 378.69 Million TWD | -47.81% |
| 2016 Q4 | 378.69 Million TWD | -31.83% |
| 2016 Q3 | 555.49 Million TWD | -21.63% |
| 2016 Q2 | 708.85 Million TWD | -5.96% |
| 2016 Q1 | 753.79 Million TWD | 3.88% |
| 2015 FY | 725.65 Million TWD | 20.88% |
| 2015 Q4 | 725.65 Million TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2014 FY | 600.31 Million TWD | 26.45% |
| 2013 Q1 | 539.44 Million TWD | 0.0% |
| 2013 FY | 474.74 Million TWD | 53.46% |
| 2012 FY | 309.36 Million TWD | 34.01% |
| 2012 Q4 | - TWD | 0.0% |
| 2011 FY | 230.85 Million TWD | 88.95% |
| 2010 FY | 122.17 Million TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sinon Corporation | 2.06 Billion TWD | 73.639% |
| Taiwan Fertilizer Co., Ltd. | 125.63 Million TWD | -332.269% |
| CH Biotech R&D Co., Ltd. | 845.16 Million TWD | 35.741% |